Ownership Summary
The institutional landscape for Lyell Immunopharma, Inc. (NASDAQ:LYEL) includes 1 filers as of the latest reporting cycle ending December 2025.
- Institutional ownership in Lyell Immunopharma edged up to 4.9% in December 2025, compared to 4.6% in September 2025.
- In percentage terms, this reflects as a holdings change of 16.22% quarter on quarter, and a decrease of 99.04% year over year.
- During the quarter, 1 institutions bought more Lyell Immunopharma shares, 0 sold shares, and 0 of the 1 total investors held their position steady.
- The total number of shares held by institutions in Lyell Immunopharma increased to 692.05K as of December 2025, a net change of up by 96.58K shares quarter on quarter, and down 6.77Mn shares year over year.
- As of December 31, 2025, Decheng Capital LLC held Lyell Immunopharma's largest shareholding position with over 692.05K shares, representing 4.89% of total outstanding shares.
- Among the most significant buyers of Lyell Immunopharma during December 2025 were Decheng Capital LLC (96.58K).
- The top 1 institutional holders of Lyell Immunopharma for the quarter ending December 2025 included Decheng Capital LLC (692.05K).